Crossmark

Reply letter: Benefits of the Bayes factor in rheumatology research

Crossref DOI link: https://doi.org/10.1016/j.rcreue.2021.06.004

Published Print: 2021-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Barber, Xavier

García-Gómez, José Alberto

Martínez-Vidal, María Paz

Álvarez-Cienfuegos, Antonio
License Information

Text and Data Mining valid from 2021-07-01
More Information

This article is maintained by: Elsevier

Article Title: Reply letter: Benefits of the Bayes factor in rheumatology research

Journal Title: Revista Colombiana de Reumatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcreue.2021.06.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rcreue.2021.04.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rcreu.2021.04.004

Content Type: simple-article

Copyright: © 2021 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.